Vspomogatel'naya immunoterapiya  VPCh-assotsiirovannykh porazheniy kozhi i slizistykh obolochek (obzor literatury)

Cite item

Full Text


About the authors

O A Mynbaev

M Yu Eliseeva


  1. Fornaciari G. The Aragonese mummies of the Basilica of Saint Domenico Maggiore in Naples Med Secoli 2006; 18 (3): 843-64.
  2. Shope RE, Hurst EW. Infectious papillomatosis of rabbits: with a note on the histopathology. J Exp Med 1933; 58 (5): 607-24.
  3. Rous P, Beard JW. The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med 1935; 62 (4): 523-48.
  4. Ayre JE. The vaginal smear; precancer cell studies using a modified technique. Am J Obstet Gynecol 1949; 58 (6): 1205-19.
  5. Papanicolaou GN. Atlas of exfloriative cytology. Cambridge, Harvard University press 1954.
  6. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I Cytologic patterns. Acta Cytol 1976; 20 (6): 505-9.
  7. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 1977; 21 (3): 379-90.
  8. Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol 1977; 21 (1): 26-31.
  9. Strauss MJ, Shaw EW, Bunting H, Melnick J. Crystalline virus-like particles from skin papillomas characterized by intranuclear inclusion bodies. Proc Soc Exp Biol Med 1949; 72 (1): 46-50.
  10. Ito Y, Evans CA. Induction of tumors in domestic rabbits with nucleic acid preparations from partially purified shope papilloma virus and from extracts of the papillomas of domestic and cottontail rabbits. J Exp Med 1961; 114 (4): 485-500.
  11. Schwarz E, Freese UK, Gissmann L et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314 (6006): 111-4.
  12. Yee C, Krishnan-Hewlett I, Baker CC et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119 (3): 361-6.
  13. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P et al. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987; 1 (3): 251-6.
  14. Pirisi L, Yasumoto S, Feller M et al. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987; 61 (4): 1061-6.
  15. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243 (4893): 934-7.
  16. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248 (4951): 76-9.
  17. von Knebel M, Rittmuller C, Aengeneyndt F. et al. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol 1994; 68 (5): 2811-21.
  18. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348 (6): 518-27.
  19. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87 (11): 796-802.
  20. Елисеева М.Ю., Мынбаев О.А. Роль вспомогательной иммунотерапии в решении проблем ВПЧ-ассоциированных патологических поражений слизистых оболочек и кожи. Акушерство и гинекология, 2011; 4: 104-11.
  21. Мынбаев О.А., Елисеева М.Ю., Доорбар Дж., Манухин И.Б. Эпидемиология, молекулярная биология, патофизиология и принципы иммунотерапии папилломавирусной инфекции. Вопр. гинекол., акушерства и перинатологии, 2009; 8 (3): 69-79.
  22. Елисеева М.Ю. и Мынбаев О.А. Вспомогательная иммунотерапия при ВПЧ-ассоциированных поражениях слизистых оболочек и кожи урогенитальной и перианальной локализации. Лечащий врач, 2010; 11: 92-101.
  23. Мынбаев О.А., Елисеева М.Ю., Манухин И.Б. и др. Применение иммуномодуляторов в гинекологии: мифы и реальность. Эффективная фармакотерапия в акушерстве и гинекологии, 2010; 5 (5): 10-3, а.
  24. Diaz-Arrastia C, Arany I, Robazetti SC et al. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clin Cancer Res 2001; 7 (10): 3031-3.
  25. Wiley DJ, Douglas J, Beutner K et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002; 35 (Suppl. 2): S210-24.
  26. Roden R, Wu TC. How will HPV vaccines affect cervical cancer? Nature Reviews Cancer 2006; 6: 753-63.
  27. Мынбаев О.А., Елисеева М.Ю., Масихи К.Н. и др. Инозин, производный пуринов - натуральный высокоэффективный иммуностимулирующий агент у трудных больных с нарушениями в иммунной системе. Новости медицины и фармации, 2010; 19 (342). http://novosti.mif-ua.com/archive/issue-14692/article-14715/ (полный текст)
  28. Мынбаев О.А., Чернов А.В., Елисеева М.Ю. Lapsus creativus или Наукообразная маниловщина. З турботою про Жiнку (Taking Care of a Woman), 2011; (3): 32-4 www.teddygroupagency.com
  29. Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol 2007; 19 (1): 61-6.
  30. Dove LM, Rosen RC, Ramcharran D et al. Virahep-C Study Group. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterology 2009; 137 (3): 873-84. Epub. 2009.
  31. Malaguarnera M, Vicari E, Calogero A et al. Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin. J Interferon Cytokine Res 2008; 28 (10): 603-9.
  32. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 2002; 107 (3): 133-44.
  33. Rönnblom L, Alm GV, Eloranta ML. The type I interferon system in the development of lupus. Semin Immunol 2011; 23 (2): 113-21.
  34. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf 1994; 10 (2): 115-50.
  35. Елисеева М.Ю., Медведев М.В., Донская Ю.В. и др. Случай сочетания кондиломатоза и опухоли Бушке-Левенштейна у супружеской пары. В печ., 2011.
  36. Индекс ATC, 2009. Классификатор системы АТС/DDD. http://www.whocc.no/atcddd
  37. Diaz-Mitoma F, Turgonyi E, Kumar A et al. Clinical improvement in chronic fatigue syndrome is associated with enhanced natural killer cell-mediated cytotoxicity: the results of a pilot study with Isoprinosine®. J Chron Fatig Syn 2003; 11 (2): 1-17.
  38. Абелевич М.М., Иванова Е.Л, Лукушкина Е.Ф. Этиопатогенетическая терапия инозином пранобексом у детей с осложненным течением аллергических заболеваний. НМЖ, 2008; 1: 60-4.
  39. Galbraith GM, Thiers J, Hochler F. A randomized doubleblind study of inosiplex (Isoprinosine) therapy in patients with alopecia totalis. J Am Acad Dermatol 1987; 16: 977-83.
  40. Janeczko J. Immunomodulatory treatment of lymphopenia after infectious mononucleosis. Przegl Epidemiol 2001; 55 (4): 433-41.
  41. Lowy M, Ledoux Corbusier M et al. Clinical and immunologic response to isoprinosine in alopecia areata and alopecia universalis: Association with autoantibodies. J Am Acad Dermatol 1985; 12: 78-84.
  42. De Simone C, Famularo G, Tzantzoglou S et al. Inosine pranobex in the treatment of HIV infection: a review. Int J Immunopharmacol 1991; 13 (1): 19-27.
  43. Cillari E, Dieli M, Lo Campo P et al. Protective effect of isoprinosine in genetically susceptible BALB/c mice infected with Leishmania major. Immunology 1991; 74: 25-30.
  44. Hersey P, Edwards A. Effect of Isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo. Int J Immunopharmacol 1984; 6: 315-20.
  45. Bekesi J, Tsang P, Wallace J, Roboz J. Immunorestorative properties of Isoprinosine in the treatment of patients at high risk of developing ARC or AIDS. J Clin Lab Immunol 1987; 24: 155-61.
  46. Hersey P, Bindon C, Bradley M, Hasic E. Effect of Isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells. Int J Immunopharmacol 1984; 6: 321-8.
  47. Milano S, Dieli M, Millott S, Dora Miceli M et al. Effect of Isoprinosine on IL-2, IFN-g, and IL-4 production in vivo and in vitro. Int JImmunopharmacol 1991; 13: 1013-8.
  48. Longley S, Dunning RL, Waldman RH. Effect of isoprinosine against challenge with A(H3N2)-Hong Kong influenza virus in volunteers. Antimicrob Agents Chemother 1973; 3 (4): 506-9.
  49. Елисеева М.Ю., Царев В.Н., Масихи К.Н. и др. Вспомогательная иммунотерапия у пациентов с иммунодефицитом и часто болеющих детей. Справ. поликлин. врача, 2010; 9: 7-14.
  50. Коколина В.Ф., Картелишев А.В., Харыбина Е.И. Эффективность комбинированного лазерного воздействия и противовирусной терапии в комплексном лечении аногенитальных кондилом у девочек. Рос. вестн. акушера-гинеколога, 2005; 4: 49-51.
  51. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci 1956; 63 (6): 1245-61.
  52. Rous P. and Kidd J.G. The activating, transforming, and carcinogenic effects of the rabbit papilloma virus (shope) upon implanted tar tumors. J Exp Med 1940; 71 (671): 787-812.

Copyright (c) 2011 Mynbaev O.A., Eliseeva M.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies